FDA sends out warning concerning popular antibiotic Z-pak

Print
Email
|

by KMOV.com Staff

KMOV.com

Posted on March 12, 2013 at 6:31 PM

Updated Wednesday, Mar 13 at 9:39 AM

An antibiotic used to treat common infections may carry serious heart risks, according to a new warning from the U.S. Food and Drug Administration.

The drug, called azithromycin but sold under the brand names Zithromax and Zmax as Z-Pak capsules, is prescribed for infections of the ears, lungs, sinuses, skin, throat, and reproductive organs, according to the FDA. But the antibiotic can interfere with the heart’s electrical activity, disturbing its rhythm with potentially fatal consequences.

“Health care professionals should consider the risk of fatal heart rhythms with azithromycin when considering treatment options for patients who are already at risk for cardiovascular events,” the FDA said in a statement.

Elderly people and those with irregular heart rates, arrhythmias, and low blood levels of potassium or magnesium are at a particularly high risk for the deadly heart condition, according to the FDA.

The warning comes 10 months after a study published in the New England Journal of Medicine found a small increase in cardiovascular deaths among people treated with Zithromax compared to those given the antibiotics amoxicillin or ciprofloxacin or no treatment at all. At the time, the FDA urged patients taking Zithromax to “not stop taking their medicine without talking to their healthcare professional” — a recommendation that stands today, despite the new warning.

Print
Email
|